Jane Street’s Heart Test Laboratories HSCS Stock Holding History

Jane Street’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-149	Closed	-$28K	–	9997
2022 Q2	$28K	Buy	+149	New	+$28.8K	﹤0.01%	9079

Other funds holding HSCS

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's HSCS Position: Q3 2022 in Review

Jane Street sold out of Heart Test Laboratories (HSCS) in Q3 2022, closing a stake of 149 shares — an estimated $28K sold.

Jane Street first reported a position in HSCS in Q2 2022 and held it in 1 quarter. The position peaked at $28K in Q2 2022. 4 funds tracked by Wall St. Rank hold HSCS as of Q3 2022.

Jane Street reported no remaining Heart Test Laboratories position as of Q3 2022 after selling out during the quarter.
Jane Street sold 149 Heart Test Laboratories shares in Q3 2022, an estimated $28K.
Jane Street first reported a position in Heart Test Laboratories in Q2 2022 and held it in 1 quarter.
Jane Street's Heart Test Laboratories position peaked at $28K in Q2 2022.
4 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.